Presentations 2021

The Liver Meeting® 2021 - The 72nd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Anaheim, CA, United States, 12-15 November 2021

Poster presentations:
Real-world effectiveness and factors associated with SVR12 in a diverse population of HCV infected persons from four large European cohorts presented by Lars Peters. POSTER


11th IAS Conference on HIV Science, 18-21 July 2021

Co-morbidities In People Living With HIV: Host- Or HIVAssociated presented by Lene Ryom MD PhD. PRESENTATION

Poster presentations:
Integrase strand transfer inhibitor (INSTI) use and cancer incidence presented by Lauren Greenberg on behalf of the RESPOND Study Group. POSTER


Conference on Retroviruses and Opportunistic Infections, Virtual, 6-10 March 2021

Pre-recorded presentations:
Association between newer antiretrovirals and increase in body mass index RESPOND presented by Loveleen Bansi-Matharu on behalf of the RESPOND Study Group. PRESENTATION

Association between integrase inhibitors (INSTIs) and cardiovascular disease (CVD) presented by Bastian Neesgaard on behalf of the RESPOND Study Group. PRESENTATION

Hepatitis C cascade of care in HIV/HCV-coinfected persons in Europe in the DAA era presented by Olga Fursa on behalf of the EuroSIDA Study Group. PRESENTATION

Hepatitis delta-related disease burden in HIV/HBV coinfected presented by Charles Béguelin on behalf of the EuroSIDA Study Group and the Swiss HIV Cohort Study. PRESENTATION